Health Secretary Matt Hancock has announced a new trial of an anti-viral drug, remdesivir, for selected NHS patients.
The trial has heralded some "promising results" as early data suggests the drug can shorten recovery times by "around four days".
Report by Connerv.
Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
